Clinical trials
Hypertension trials in Nigeria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 3 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Unknown status | 6 |
| Recruiting | 4 |
| Active, not recruiting | 3 |
| Enrolling by invitation | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Washington University School of Medicine | 5 |
| University of Ibadan | 4 |
| NYU Langone Health | 2 |
| University of Abuja | 2 |
| Adebayo Joshua Adeniyi | 1 |
| AstraZeneca | 1 |
| Dr. Dike Ojji | 1 |
| George Medicines PTY Limited | 1 |
| Healthsystem Plus | 1 |
| Hiroshima University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 31 |
| Diabetes Mellitus | 6 |
| Cardiovascular Diseases | 3 |
| Diabetes Mellitus, Type 2 | 3 |
| Acquired Immunodeficiency Syndrome | 2 |
| Dyslipidemias | 2 |
| Obesity | 2 |
| Renal Insufficiency, Chronic | 2 |
| Stroke | 2 |
| Acute Kidney Injury | 1 |
Trials
Showing 51 to 31 of 31. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.